Statistics in Trials Interest Group (STInG)

Juggling percentages

ACTA STInG is a group of more than 150 statisticians and clinicians with an interest in statistics in clinical trials.

  • To improve the quality of clinical trials within Australia by strengthening links among trial statisticians.
  • To develop a structured support network for trial statisticians across Australia, within which different centres provide specialist support for particular trial designs or clinical areas.
  • To work with ACTA to increase recognition and advocate within the research community (including ethics committees and with the NHMRC) for the importance of professional statistical support in the conduct of trials.
  • To promote collaborative methodological research among trial statisticians in clinical trial design and analysis.
  • To promote professional standards of statistics in trials and where possible harmonise attitudes to the practice of statistics in clinical trials settings within Australia.
  • To develop a strategy for training and mentoring future generations of trial statisticians within Australia.

The executive committee of this group is very engaged and meets frequently to advance the initiatives of the group. ACTA STInG also releases a newsletter twice a year. ACTA STInG has no activity funding, so the group works through in-kind support and voluntary coordination.

STInG members are invited to view two online directories that include details of statisticians who may be available for support and collaboration, as well as statisticians who may be suitable to invite to be on a Data and Safety Monitoring Board (DSMB). 

If you would like to become a member of ACTA STInG, please fill out this form.

Our 2022 ACTA STInG Award winner

The PADDI Trial

  • Chief Investigator: Prof Tomás Corcoran
  • Network or investigator group: Australian and New Zealand College of Anaesthetists
    (ANZCA) Clinical Trials Network
  • This trial presented that dexamethasone can be safely administered to patients to
    prevent nausea and vomiting when undergoing surgery, without concern about wound
    infections.
  • View the SAP

 

Our 2021 ACTA STInG Award winner

The PEPTIC Trial

  • Chief Investigator: Prof Andrew Forbes
  • Network or investigator group: ANZICS Clinical Trials Group (Australian and New Zealand Intensive Care Society)
  • This trial studied the effect of stress ulcer prophylaxis with proton pump inhibitors vs. Histamine-2 receptor blockers on in hospital mortality among ICU patients with invasive mechanical ventilation
  • View the SAP

 

Our 2020 ACTA STInG Award winner

The ENZAMET Trial

  • Chief Investigators: Prof Ian Davis and Prof Christopher Sweeney
  • Network or investigator group: ANZUP Cancer Trials Group
  • The ENZAMET trial was designed to test whether survival of men with metastatic prostate cancer could be improved even further by adding enzalutamide to hormone therapy right at the beginning of treatment, instead of waiting for the cancer to grow after prior hormone treatment.
  • View the SAP

Group Leadership

  • Prof Katherine Lee
  • Prof Andrew Forbes
  • Ms Sabine Braat
  • Dr Annie Solterbeck
  • Ms Elaine Pascoe
  • Dr Julie Marsh
  • Prof Laurent Billot
  • Dr Lisa Yelland
  • Prof Stephane Heritier

Board Sponsors

  • Prof Steve Webb
  • Prof Chris Reid
  • Ms Leonie Wilcox

Latest Resources

Latest Events